Are patients undergoing treatment of hyperlipidaemia with statins the best candidates for early cardiac rehabilitation

Published on Nov 8, 2011in Archives of Medical Science2.807
· DOI :10.5114/AOMS.2011.25548
Rafał Celiński2
Estimated H-index: 2
Anna Grzywa-Celińska5
Estimated H-index: 5
+ 2 AuthorsJerzy Mosiewicz12
Estimated H-index: 12
The role of statins in the primary and secondary prevention of cardiovascular events is well known. An important adverse event associated with statin treatment is myopathy; intensive physical effort in patients treated with statins increases the risk of muscle injury/myopathy. In this article we discuss the benefits and risks associated with statin treatment in patients undergoing cardiac rehabilitation after acute coronary syndromes and/or coronary revascularization procedures. In our opinion, the benefits of the secondary prevention of coronary heart disease achieved with statins seem to outweigh the hazards associated with statin therapy. The careful selection of patients for both treatment with statins and the gradual intensification of physical training in the course of cardiac rehabilitation appears to constitute an important element of the therapeutic approach.
📖 Papers frequently viewed together
3 Citations
14 Citations
51 Citations
#1Chris J. PackardH-Index: 1
2 Citations
: The role of statins in primary and secondary prevention of cardiovascular incidents cannot be questioned. However, it is commonly known, that their use, especially in high doses, can cause side effects. Our study reports the case of female patient who because of an episode of unstable angina underwent the percutaneous coronary intervention (PCI) of right coronary artery (RCA), and afterwards received the hypolipemic treatment of simvastatin in the dose of 80 mg/day. After the PCI she participa...
2 Citations
#1Paul M. Coen (Purdue University)H-Index: 29
#2Michael G. Flynn (Purdue University)H-Index: 27
Last. Robert E. Hannemann (Purdue University)H-Index: 13
view all 5 authors...
Statin treatment and exercise training can improve lipid profile when administered separately. The efficacy of exercise and statin treatment combined, and its impact on myalgia and serum creatine kinase (CK) have not been completely addressed. The purpose of this study was to determine the effect of statin treatment and the addition of exercise training on lipid profile, including oxidized low-density lipoprotein (oxLDL), and levels of CK and alanine transaminase. Thirty-one hypercholesterolemic...
29 CitationsSource
#1John AngelopoulosH-Index: 4
Last. John S. SampalisH-Index: 52
view all 5 authors...
Introduction: Patients, who have above-target low-density lipoprotein cholesterol (LDL-C) levels, are at increased risk for developing coronary heart disease and cardiovascular disease. Statin monotherapy, which decreases the production of exogenous cholesterol, might not be enough to decrease LDL-C levels. Coadministration of a cholesterol absorption inhibitor with a statin may be more effective at decreasing serum LDL-C levels and improving overall lipid profiles. To assess the effectiveness o...
15 Citations
Purpose of review Genetic predisposition to statin myopathy is a rapidly expanding area of investigation. This review summarizes the latest information on genetic risk factors associated with statin-induced myopathy. Genetic determinants involved in both pharmacokinetics of statins and metabolic muscle diseases are discussed. Data are provided on the prevalence of statin use in the United States; incidence of associated myopathy; terminology relating to statin myopathy and genetic susceptibility...
63 CitationsSource
Purpose of review The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) are the cornerstone of therapy for dyslipidemia. A significant portion of patients are not adherent to statin therapy, due to either intolerance from muscle symptoms or fears of myopathy reported in the media. The diagnosis and management of patients with statin-induced myopathy will be reviewed. Recent findings Based on a review of healthy clinical-trial participants, the placebo-corrected incidences of m...
206 CitationsSource
#1Kenneth A. Antons (Scripps Mercy Hospital)H-Index: 1
#2Craig D. Williams (Purdue University)H-Index: 14
Last. Paul S. Phillips (Scripps Mercy Hospital)H-Index: 12
view all 4 authors...
Abstract Fear of muscle toxicity remains a major reason that patients with hyperlipidemia are undertreated. Recent evaluations of statin-induced rhabdomyolysis offer new insights on the clinical management of both muscle symptoms and hyperlipidemia after rhabdomyolysis. The incidence of statin-induced rhabdomyolysis is higher in practice than in controlled trials in which high-risk subjects are excluded. Accepted risks include age; renal, hepatic, and thyroid dysfunction; and hypertriglyceridemi...
184 CitationsSource
#1Karen E. Hansen (UW: University of Wisconsin-Madison)H-Index: 24
Last. James H. SteinH-Index: 69
view all 4 authors...
Background Published studies regarding statin-associated myopathy may describe more dramatic patient presentations, potentially leading to inaccurate characterization of the condition. Furthermore, long-term outcomes and responses to statin rechallenge in patients with statin-associated myopathy are largely unknown. Methods The University of Wisconsin Hospital and Clinics Medical Informatics Department identified 437 patients with International Classification of Diseases, Ninth Revision codes po...
193 CitationsSource
#1Eric BruckertH-Index: 82
#2Gilles HayemH-Index: 1
Last. Bernard BégaudH-Index: 54
view all 5 authors...
Objectives: To characterize the risk factors, rate of occurrence, onset, nature and impact of mild to moderate muscular symptoms with high-dosage HMG-CoA reductase inhibitor (statin) therapy in general practice.
943 CitationsSource
#1James A. de LemosH-Index: 105
#2Michael A. BlazingH-Index: 48
Last. Eugene BraunwaldH-Index: 266
view all 16 authors...
ContextLimited data are available evaluating how the timing and intensity of statin therapy following an acute coronary syndrome (ACS) event affect clinical outcome.ObjectiveTo compare early initiation of an intensive statin regimen with delayed initiation of a less intensive regimen in patients with ACS.Design, Setting, and ParticipantsInternational, randomized, double-blind trial of patients with ACS receiving 40 mg/d of simvastatin for 1 month followed by 80 mg/d thereafter (n = 2265) compare...
1,174 CitationsSource
Cited By1
In the current issue of the Archives of Medical Science two studies from the same group, an academic community cardiology practice [1, 2], address the issue of the impact of the implementation of secondary cardiovascular disease (CVD) prevention guidelines on the long-term clinical outcome in patients with established coronary artery disease (CAD).
3 CitationsSource